Clinical experience with cabergoline, a new ergoline derivative, in the treatment of Parkinson's disease.
Jori
M C
MC
Farmitalia Carlo Erba Laboratories, Milan.
Franceschi
M
M
Giusti
M C
MC
Canal
N
N
Piolti
R
R
Frattola
L
L
Bassi
S
S
Calloni
E
E
Mamoli
A
A
Camerlingo
M
M
D000284:Administration, Oral; D000368:Aged; D000978:Antiparkinson Agents; D000077465:Cabergoline; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004873:Ergolines / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D004873:Ergolines; D000077465:Cabergoline